Viral Vectors

We develop and manufacture viral vectors that meet clinical and commercial demands for gene therapy products

Milan lab

Viral Vectors: AAV, LVV, RVV

AGC Biologics scientists have two decades of viral vector-based gene therapy expertise and specialize in adeno-associated viral vectors (AAV), lentiviral vectors (LVV), and retroviral vectors (RVV). Our sites in the U.S. and Italy have supported four commercial products. 

Our ready-to-use platform capabilities for AAV and LVV programs are built on cell factories and bioreactors using adherent and suspension processes, designed entirely in-house. 

Our quality systems, manufacturing scales, and regulatory expertise allow us to meet both clinical and commercial viral vector demands. Moreover, our scale-down capabilities provide flexible and cost-effective solutions for process development and pre-clinical studies. 

Viral Vectors Production and Manufacturing Services  

  • Viral Vectors services including development, characterization, and manufacturing (PD/cGMP environment)

  • Small, medium, and large-scale equipment for both adhesion and suspension-based processes

  • A reliable and flexible platform for various scales of AAV production with different serotypes

  • Plug-and-play platform for large-scale AAV and LVV manufacturing that can be adapted to virtually any program

  • cGMP viral vector manufacturing at various scales up to 2,000L across two global sites

  • iCELLis 500 bioreactor technology used for adherent processes up to 200L, and for scale-up of adhesion-based processes

  • 160+ in-house analytical tests with custom designs for clinical and commercial supply

  • Quality systems and teams of scientists with two decades of global regulatory experience in the cell and gene field

Locations offering Viral Vector

Interested in learning more?

Contact our team